Skip to main content

Welcome to the CRL Insurer Services blog! Here you will find commentary from our dedicated team of medical directors and industry leaders on lab research and trends, innovative services and solutions, and what’s new at CRL. Click the button below to get the latest news directly to your inbox. Questions? Contact us at ILSsales@crlcorp.com.

Sign Up for Updates

 

2020 US Mortality Results: How do they compare to prior years?

June 17, 2021

Dr. Michael Fulks, Consulting Medical Director to CRL, comments on the 2020 leading causes of death in a COVID-19 world…. Read More

Tags: Cancer, Covid 19, Heart Disease, Life Insurance, Mortality

The Emerging Marijuana Challenge: Δ8-THC

May 18, 2021

Delta-8 Compound Marijuana testing is used by a number of life insurers in the risk assessment process. New chemical entities… Read More

Tags: Delta 8 Thc, Drug Test, Insurance, Laboratory, Marijuana

Urine Protein Tests: A Mortality Predictor in Life Insurance Populations

March 31, 2021

Urine protein tests offer a simple way for insurance companies to obtain an important predictor of life risk. CRL recently… Read More

Tags: Healthcare, Kidney, Life Insurance, Medical Research, Mortality

Bad Habits and the Pandemic

March 10, 2021

Dr. Steven Rigatti, Consulting Medical Director to CRL, comments on alcohol and tobacco usage rates from a pre-pandemic period to… Read More

Tags: Alcohol, Covid 19, Covid 19 Crisis, Pandemic, Stay At Home

New CRL COVID-19 Research: Viral Load in Asymptomatic vs. Symptomatic Cases is Similar

February 22, 2021

A new paper on COVID-19 research from CRL doctors was published this week. Over 460k samples collected from July 2020… Read More

Tags: Covid 19, Covid 19 Crisis, Covid 19 Testing, Covid Update, Data

Trends in Nicotine Misrepresentation

January 20, 2021

A fundamental underwriting principal is to treat like risks in a similar manner. This fairness doctrine is a key to… Read More

Tags: Cigarettes, Insurance, Mortality, Nicotine, Risk

COVID-19 Antibody Prevelance Increased throughout 2020: New Research from CRL

January 7, 2021

Dr. Robert Stout, Co-Founder and Chief Scientific Officer at CRL, and Dr. Steven Rigatti, Consulting Medical Director with CRL, conducted… Read More

Tags: Coronavirus, Covid 19, Covid 19 Crisis, Life Insurance, Risk Management

CRL Acquires Confirm BioSciences

December 14, 2020

See below for details on the latest CRL acquisition. We are pleased to share that CRL has acquired Confirm BioSciences, a… Read More

Tags: Acquisition, Business, Laboratory, Life Insurance, Mortality

Are You Overpricing Applicants with HbA1c Elevations?

November 11, 2020

There are many articles that can help answer the question of applicant hemoglobin A1c values, including this study from CRL: Relationship… Read More

Tags: Diabetes, Diabetic, Life Insurance, Mortality, Underwriting

Epigenetics White Paper on Technology & Innovation: CRL Doctor Expertise

November 4, 2020

Dr. Heather Fehling, Chief Scientific Officer of Molecular Diagnostics at CRL, was honored to join the Society of Actuaries Epigenetics… Read More

Tags: Epigenetics, Genetics, Life Insurance, Mortality, Science

If you would like to sign up to receive email updates from the Insurer team, please click here.